AbCellera Biologics (ABCL) Cash from Operations (2020 - 2026)
AbCellera Biologics (ABCL) posted Cash from Operations of 33523000.0 for Q1 2026, up 3.51% on a QoQ basis from 34743000.0 in Q4 2025, and down 190.14% year-over-year from 37189125.49 in Q1 2025.
AbCellera Biologics (ABCL) Cash from Operations (2020 - 2026) Analysis & Trends
AbCellera Biologics' Cash from Operations history runs 7 years deep, the most recent figure standing at 33523000.0 for Q1 2026.
- Quarterly Cash from Operations fell 190.14% year-over-year to 33523000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 153264000.0 (down 95.48% YoY) and the FY2025 annual result came in at 131295000.0, down 20.95% from the prior year.
- Cash from Operations was 33523000.0 for Q1 2026 at AbCellera Biologics, up from 34743000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 273015000.0 in Q2 2022 and bottomed at 126786000.0 in Q3 2022.
- A 5-year average of 2346529.41 and a median of 28882000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations surged 284.97% — and 2024, when it tumbled 27147.17%.
- AbCellera Biologics' Cash from Operations stood at 30912000.0 in 2022, then sank by 163.44% to 19611000.0 in 2023, then surged by 59.21% to 8000000.0 in 2024, then slumped by 334.29% to 34743000.0 in 2025, then grew by 3.51% to 33523000.0 in 2026.
- Business Quant data shows ABCL's Cash from Operations at 33523000.0 in Q1 2026, 34743000.0 in Q4 2025, and 52594000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -33.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.52 Mn |
| Mar 31, 2026 | -33.52 Mn |
| Dec 31, 2025 | -34.74 Mn |
| Dec 31, 2025 | -34.74 Mn |
| Sep 30, 2025 | -52.59 Mn |
| Sep 30, 2025 | -52.59 Mn |
| Jun 30, 2025 | -32.40 Mn |
| Jun 30, 2025 | -32.40 Mn |
| Mar 31, 2025 | -11.55 Mn |
| Mar 31, 2025 | -11.55 Mn |
| Dec 31, 2024 | -8.00 Mn |
| Dec 31, 2024 | -8.00 Mn |
| Sep 30, 2024 | -28.88 Mn |
| Sep 30, 2024 | -28.88 Mn |
| Jun 30, 2024 | -29.97 Mn |
| Jun 30, 2024 | -29.97 Mn |
| Mar 31, 2024 | -41.71 Mn |
| Mar 31, 2024 | -41.71 Mn |
| Dec 31, 2023 | -19.61 Mn |
| Dec 31, 2023 | -19.61 Mn |